Zhejiang Hisun Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000013Z2
CNY
10.60
1.18 (12.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
9,679.02
10,288.13
11,929.39
12,028.64
11,280.17
10,980.12
10,088.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,679.02
10,288.13
11,929.39
12,028.64
11,280.17
10,980.12
10,088.77
Raw Material Cost
5,937.90
6,682.66
7,501.87
7,608.11
6,774.41
6,636.13
6,163.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
155.61
218.26
288.68
348.15
425.08
531.33
405.12
Selling and Distribution Expenses
2,664.56
2,892.91
3,031.87
3,169.57
3,076.41
3,693.48
3,112.00
Other Expenses
11.46
7.63
3.76
-6.23
-8.44
27.99
15.43
Total Expenditure (Excl Depreciation)
8,872.68
9,870.17
10,860.01
11,063.50
10,191.51
11,140.86
9,834.54
Operating Profit (PBDIT) excl Other Income
806.3
418
1069.4
965.1
1088.7
-160.7
254.20000000000002
Other Income
279.23
140.23
313.80
265.98
382.70
2,655.37
162.23
Operating Profit (PBDIT)
2,093.66
1,480.58
2,312.79
2,070.77
2,234.96
3,056.42
1,089.48
Interest
155.61
218.26
288.68
348.15
425.08
531.33
405.12
Exceptional Items
-141.26
-240.25
-137.62
-48.35
9.25
-1,136.27
-69.21
Gross Profit (PBDT)
3,741.12
3,605.47
4,427.52
4,420.53
4,505.76
4,343.99
3,925.63
Depreciation
1,083.92
1,044.57
1,045.52
954.33
881.31
888.30
747.17
Profit Before Tax
712.87
-22.49
840.98
719.94
937.82
500.51
-132.01
Tax
126.76
14.15
192.19
133.56
180.97
183.83
124.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
601.18
-93.17
488.86
486.89
417.19
93.07
-492.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
601.18
-93.17
488.86
486.89
417.19
93.07
-492.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-9.87
-3.84
2.37
23.74
305.97
230.19
255.50
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
591.31
-97.01
491.23
510.63
723.17
323.27
-236.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,341.35
8,101.97
8,079.19
7,303.28
6,678.67
6,274.22
6,183.50
Earnings per share (EPS)
0.52
-0.08
0.42
0.43
0.43
0.1
-0.51
Diluted Earnings per share
0.52
-0.08
0.42
0.43
0.43
0.1
-0.51
Operating Profit Margin (Excl OI)
7.55%
2.87%
7.99%
7.07%
8.61%
-4.44%
1.79%
Gross Profit Margin
18.56%
9.93%
15.81%
13.92%
16.13%
12.65%
6.1%
PAT Margin
6.21%
-0.91%
4.1%
4.05%
3.7%
0.85%
-4.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -5.92% vs -13.76% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 709.59% vs -119.75% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 35.36% vs -32.95% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -28.72% vs -24.39% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Zhejiang Hisun Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
9,679.02
0
9,679.02
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,679.02
0
9,679.02
Raw Material Cost
5,937.90
0
5,937.90
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
155.61
0
155.61
Selling and Distribution Expenses
2,664.56
0
2,664.56
Other Expenses
11.46
0.00
11.46
Total Expenditure (Excl Depreciation)
8,872.68
0
8,872.68
Operating Profit (PBDIT) excl Other Income
806.34
0.00
806.34
Other Income
279.23
0
279.23
Operating Profit (PBDIT)
2,093.66
0
2,093.66
Interest
155.61
0
155.61
Exceptional Items
-141.26
0
-141.26
Gross Profit (PBDT)
3,741.12
0
3,741.12
Depreciation
1,083.92
0
1,083.92
Profit Before Tax
712.87
0
712.87
Tax
126.76
0
126.76
Provisions and contingencies
0
0
0.00
Profit After Tax
601.18
0
601.18
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
601.18
0
601.18
Share in Profit of Associates
0
0
0.00
Minority Interest
-9.87
0
-9.87
Other related items
0.00
0.00
0.00
Consolidated Net Profit
591.31
0
591.31
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,341.35
0
8,341.35
Earnings per share (EPS)
0.52
0
0.52
Diluted Earnings per share
0.52
0
0.52
Operating Profit Margin (Excl OI)
7.55%
0%
0.00
7.55%
Gross Profit Margin
18.56%
0%
0.00
18.56%
PAT Margin
6.21%
0%
0.00
6.21%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 967.90 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -5.92% vs -13.76% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 59.13 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 709.59% vs -119.75% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 181.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 35.36% vs -32.95% in Dec 2023

Annual - Interest
Interest 15.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -28.72% vs -24.39% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.55%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023